$61.56 +0.61 (%) Teva Pharma Ind Shs Sponsored American Deposit Receipt Repr 1 Sh - NYSE

Jul. 2, 2015 | 04:00 PM

Partner Headlines

  1. Momenta Pharma

    IBD | Jul. 2, 2015 | 18:46PM EST
  2. Momenta Downgraded After Stock Price Doubles

    IBD | Jul. 2, 2015 | 12:11PM EST
  3. Teva-Xenon Arthritis Pain Drug Fails Midstage Trial

    IBD | Jul. 1, 2015 | 15:24PM EST
  4. Wednesday's Mid-Day Movers: Chubb, Rock Creed, RADA Win; Peabody Energy, Ballard Fall

    Benzinga | Jul. 1, 2015 | 13:44PM EST
  5. Unusual Covered Call Opportunity Teva Pharmaceuticals

    Benzinga | Jun. 30, 2015 | 09:37AM EST
  6. Alder Bio Up As Credit Suisse Lauds Migraine Drug

    IBD | Jun. 24, 2015 | 15:49PM EST
  7. New America's IPO Stock Winners: Fitbit, Arista

    IBD | Jun. 24, 2015 | 12:51PM EST
  8. ObamaCare Enables Health Insurer Merger Mania

    IBD | Jun. 23, 2015 | 08:02AM EST
  9. Paul Tudor Jones Buys Stakes in ADP and Visa

    GuruFocus | Jun. 19, 2015 | 17:35PM EST
  10. Teva Migraine Drug Succeeds In Midstage Trial

    IBD | Jun. 18, 2015 | 17:57PM EST
  11. Teva Migraine Drug Succeeds In Midstage Trial

    IBD | Jun. 18, 2015 | 12:27PM EST
  12. Teva to Present New Findings at the American Headache Society (AHS) Meeting

    Benzinga | Jun. 18, 2015 | 08:32AM EST
  13. How High Can Eagle Pharmaceuticals Fly On Teva Deal?

    IBD | Jun. 17, 2015 | 13:37PM EST
  14. Teva's Mylan bid hits snag

    IBD | Jun. 16, 2015 | 18:45PM EST
  15. Teva's Auspex Buyout Pays, But Mylan Bid Hits Snag

    IBD | Jun. 16, 2015 | 15:39PM EST
  16. Teva Advances Pipeline of Movement Disorder Assets with Announcement of Positive Top-Line Data from the First Pivotal Study of Investigational Treatment for Patients with Tardive Dyskinesia

    Benzinga | Jun. 16, 2015 | 08:02AM EST
  17. Top Biotech Stock Files For New Drug, In Buy Range

    IBD | Jun. 15, 2015 | 17:27PM EST
  18. Activist Hedge Fund Manager Has Strong Focus on Health Care Stocks

    GuruFocus | Jun. 11, 2015 | 13:41PM EST
  19. New Migraine Drugs Could Ease Investors' Headaches

    IBD | Jun. 11, 2015 | 08:02AM EST
  20. Benzinga's M&A Chatter for Tuesday June 9, 2015

    Benzinga | Jun. 9, 2015 | 19:18PM EST
  21. Leon Cooperman's Top Holdings Look Attractive

    GuruFocus | Jun. 9, 2015 | 10:48AM EST
  22. Teva Pharmaceuticals

    IBD | Jun. 8, 2015 | 19:04PM EST
  23. 6-K from Teva Pharma Shows Letter from CEO Vigodman, Chair Peterburg to Mylan Chair Coury

    Benzinga | Jun. 8, 2015 | 08:56AM EST
  24. Mobileye Hangs Just Below Buy Point In Deep Cup Base

    IBD | Jun. 3, 2015 | 18:19PM EST
  25. Perrigo buys Glaxo OTC drugs

    IBD | Jun. 2, 2015 | 18:40PM EST
  26. Will Perrigo's Glaxo Buy Make It Too Pricey?

    IBD | Jun. 2, 2015 | 13:08PM EST
  27. Mylan Sends Letter to Teva CEO

    Benzinga | Jun. 1, 2015 | 16:04PM EST
  28. Teva Announces Exclusive Launch of Generic Actonel Tablets in the United States

    Benzinga | Jun. 1, 2015 | 08:33AM EST
  29. Teva to pay $1.2 bil to settle

    IBD | May. 28, 2015 | 18:54PM EST
  30. Regeneron, Lannett Among The 4 Top-Rated Drug Stocks

    IBD | May. 28, 2015 | 08:02AM EST
  31. Benzinga's M&A Chatter for Wednesday May 27, 2015

    Benzinga | May. 27, 2015 | 20:08PM EST
  32. TEVA PHARMA

    IBD | May. 27, 2015 | 18:58PM EST
  33. Actavis Stock - A Must Have For Long-Term Investors

    GuruFocus | May. 27, 2015 | 11:34AM EST
  34. Big Pharma Companies Are Betting On Regenerative Medicine - Should You?

    GuruFocus | May. 26, 2015 | 13:35PM EST
  35. Stanley Druckenmiller's Top 5 New Stocks

    GuruFocus | May. 25, 2015 | 23:11PM EST
  36. Endo International Acquires Par Pharmaceuticals For $8 Billion

    GuruFocus | May. 21, 2015 | 10:48AM EST
  37. Endo Buying Par Pharma To Become Top Generics Player

    IBD | May. 18, 2015 | 10:38AM EST
  38. IPO Stock Watch: Alder Soars On Migraine Drug Results

    IBD | May. 15, 2015 | 16:31PM EST
  39. U.S. Loves Europe As Pharma, Energy Boost M&A

    IBD | May. 14, 2015 | 17:45PM EST
  40. Actavis Offers Post-Allergan Guidance; Ligand Jumps

    IBD | May. 11, 2015 | 18:36PM EST
  41. Actavis Q1 Beats Estimates, Includes Allergan In 2015 Guidance

    IBD | May. 11, 2015 | 10:59AM EST
  42. Benzinga's Weekend M&A Chatter

    Benzinga | May. 10, 2015 | 20:50PM EST
  43. Report: Mylan Might See Higher Bid From Teva

    Benzinga | May. 8, 2015 | 14:20PM EST
  44. Jim Chanos, Kyle Bass Rip Oil And Pharma At SALT 2015

    Benzinga | May. 7, 2015 | 17:39PM EST
  45. Alexion's $8.4 Billion Synageva Buyout Spooks Street

    IBD | May. 6, 2015 | 18:20PM EST
  46. Leading Stock Mallinckrodt Delivers Strong Results As Base Forms

    IBD | May. 6, 2015 | 18:13PM EST
  47. Mylan Q1 Mixed; Abiomed, Mallinckrodt, Zoetis Beat

    IBD | May. 5, 2015 | 18:59PM EST
  48. Report Sees 'Cognitive Dissonance' In Mylan's Internal Price Target

    Benzinga | May. 4, 2015 | 16:30PM EST
  49. M&A Fever Grips Drugmakers

    IBD | May. 1, 2015 | 18:44PM EST
  50. Is The Drug Industry's Wedding Dance Nearly Finished?

    IBD | May. 1, 2015 | 16:08PM EST
Trading Center
×

You are using adblocking software

Want access to all of Investopedia? Add us to your “whitelist”
so you'll never miss a feature!